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Abbreviations 
 
Ac  acetyl 
aq.  aqueous 
bpy  2,2’-bipyridyl 
Boc  tert-butoxycarbonyl 
Bu  butyl 
cat.  catalytic 
COX  cyclooxygenase 
Cp*  pentamethylcyclopentadienyl 
Cy  cyclohexyl 
DIBAL  diisobutylaluminium hydride 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
eq.  equivalent(s) 
ESI  electrospray ionization 
Et  ethyl 
EY  Eosin Y 
FT/IR  Fourier transform infrared spectroscopy 
GPC  gel permeation chromatography 
h  hour(s) 
Hantzsch ester diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate 
LED  light emitting diode 
M  molar 
Me  methyl 
Mes  2,4,6-trimethylphenyl 
min  minute(s) 
MW  microwave 
n  normal 
naph  naphthyl 
NMR  nuclear magnetic resonance 
Ph  phenyl 
phd  1,10-phenanthroline-5,6-dione 
Piv  pivaloyl 
ppb  parts per billion 
ppm  parts per million 
PPTS  pyridinium p-toluenesulfonate 
iPr  2-propyl 
quant.  quantitative 
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rt  room temperature 
rpm  rotation per minute 
SM  starting material 
salophen N,N’-bis(salicylidene)-1,2-phenylenediamine 
T  temperature 
TEMPO  (2,2,6,6-tetramethylpiperidin-1-yl)oxyl 
THF  tetrahydrofuran 
WSCI  1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
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1. Introduction 
 
  20th century has witnessed a substantial development of organometallic chemistry, 
not only in its basic understandings but also in its synthetic applications. As is evident 
from an example of Pd-catalyzed cross coupling reactions, redox behavior of transition 
metals is often indispensable for their catalytic activity (Scheme 1). However, due to the 
rapid expansion of demands for metal resources along with industrialization and 
economic growth in the developing world, supply of transition metals is expected to be 
at risk. According to a survey by National Institute for Materials Science (NIMS), it is 
predicted that transition metals such as Mn, Fe, Co, Ni, Cu, Mo, Pd, Ag, W, Pt and Au 
are expected to be run out by 2050 
(http://www.nims.go.jp/research/elements/rare-metal/probrem/dryness.html Accessed 
on January 2, 2017). Thus, in order to achieve sustainable development in the 21st 
century, a novel alternative to the transition metal catalysts is in high demand. In my 
Ph.D. course, I focused on two transition-metal-catalyzed C-H bond functionalization 
reactions, and developed two related organocatalytic transformations by utilizing 
organic compounds which facilitate redox processes. I believe that these redox 
organocatalysis would provide new prospects for the sustainable development of 
synthetic organic chemistry. 
 
 
Scheme 1. Palladium as a redox mediator in cross coupling reactions 
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2. Metal-free C(3)-H arylation of coumarins promoted by catalytic 
amounts of 5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin 
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2-1. Research background 
 
2-1-1. Coumarins in chemical science 
 
  Coumarins represent a desirable structural motif in pharmaceutical science, chemical 
biology or materials chemistry.1-3 For example, marketed drugs such as novobiocin or 
warfarin contains coumarin motif in its central skeleton. Recently, 3-arylcoumarins 
were identified as a selective monoamine oxidase-B (MAO-B) inhibitor and are 
recognized as new lead compounds for the treatment of Alzheimer ’s or Parkinson’s 
disease (Scheme 2).1 Moreover, controllable fluorescent property of coumarin derivatives 
is intensively utilized in chemical biology.2 In addition, coumarin-based dyes are 
frequently employed in light-harvesting materials as efficient dopants in light-emitting 
diodes.3 Due to the wide range of application studies, facile functionalization of 
coumarin skeleton which enables rapid access to its new derivatives would contribute to 
various fields of chemical science. 
 
 
Scheme 2. Representative coumarin derivatives in pharmaceutical science 
 
2-1-2. C-H arylation of coumarins 
 
As one of the most well-developed derivatization methods for coumarins, I focused on 
site selective C-H arylation reactions. Palladium catalysis is versatile in many types of 
C-H arylation reactions, and has also been employed for the C(3)-H or C(4)-H arylation 
of coumarin derivatives.4 For example, Duan reported a palladium-catalyzed, Heck-type 
C(4)-H arylation of coumarins with arylboronic acids and molecular oxygen (Scheme 
3).4d This Heck-type transformation is beneficial because no prefunctionalization of 
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coumarin skeleton is necessary. However, functional group tolerance of this 
transformation had a room for improvement. Although alkyl, chloro, nitro, or hydroxy 
groups were tolerated in this transformation, bromo-substituted arylboronic acid 
produced complex mixture of the product because Suzuki-Miyaura coupling occurred 
simultaneously. Considering that bromo group is useful for subsequent transformations, 
this observation could be a typical drawback of palladium-catalyzed C-H arylation 
methods. In addition, high cost and toxicity of palladium are disadvantageous for the 
potential application to the preparation of pharmaceutical agents. 
 
 
Scheme 3. Palladium-catalyzed C(4)-H arylation of coumarin4d 
 
For another example of C-H arylation of coumarins, Meerwein arylation is known as a 
classical method (Scheme 4).5 In a typical Meerwein arylation, transition metal 
catalysts produce aryl radicals by one electron reduction of aryldiazonium salts. Then, 
aryl radicals attack 3 position of coumarins, affording the C(3)-H arylated product. 
However, there remain several challenges in this classical approach. In the case of 
Meerwein-type C-H arylation, substrate generality is yet limited because of the side 
reactions of aryldiazonium salts. Also, aqueous solvents are required, making the 
expansion of substrate scope difficult. Moreover, yields of the product are often low to 
moderate (typically < 50%) for the copper catalyzed reaction.6 
 
 
Scheme 4. Classical Meerwein arylation for C(3)-H arylation of coumarin6 
 
Recently, König reported a visible light driven C(3)-H arylation of coumarin by 
[Ru(bpy)3]2+ photoredox catalyst (Scheme 5).7 However, substrate scope was not 
extensively investigated and requirement of precious ruthenium based catalyst is a 
drawback of the transformation. 
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Scheme 5. Meerwein arylation by [Ru(bpy)3]2+ photoredox catalysis7 
 
2-1-3. Metal-free C-H functionalization of (hetero)arenes 
 
  In order to overcome the drawbacks of transition-metal-mediated Meerwein arylation, 
metal-free Meerwein-type arylation has been intensively investigated.8-14 As a 
representative example, in 2012, König reported a metal-free, visible light mediated 
C-H arylation of heteroarenes using Eosin Y as an organocatalyst (Scheme 6).8a  
 
 
Scheme 6. Eosin Y catalyzed C-H arylation of heterocycles8a 
 
It is proposed that the reaction proceeds via the one electron reduction of 
aryldiazonium salts by the excited photocatalyst, addition of aryl radical to the 
unsaturated bond of heteroarenes, and one electron oxidation of the radical 
intermediate by the oxidized form of the photocatalyst (Scheme 7). Due to the mild 
reaction conditions (room temperature, visible light), high yield and excellent functional 
group tolerance are achieved.  
 
Scheme 7. Plausible reaction mechanisms for the Eosin Y catalyzed C-H arylation 
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However, the scope of heteroarenes of this organocatalytic C-H arylation is limited to 
reactive 5-membered heterocycles (furans, thiophenes, and pyrrole derivatives). 
Following this method, I tried the C-H arylation of coumarins, but the desired product 
was obtained in only 8% yield (Scheme 8). This result suggests that the present 
organocatalytic C-H arylation is not applicable to coumarins.  
 
 
Scheme 8. Eosin Y catalyzed C(3)-H arylation of coumarin 
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2-2. Reaction design 
 
  In the course of the evaluation of Eosin Y catalyzed functionalization of coumarins, 
bleaching of the photocatalyst was observed after long reaction time under deaerated 
conditions (Scheme 9).  
 
 
Scheme 9. Bleaching of Eosin Y during the arylation of coumarin 
 
I suspected that decomposition of Eosin Y could be one reason for the low reactivity. 
Therefore, I hypothesized that high stability of the catalyst during the reaction could be 
important for high catalytic efficiency. In that context, I planned to employ metal-free 
porphyrin as a new organocatalyst for the C-H arylation. Metal-free porphyrin is known 
to possess a reversible one electron redox activity, and is widely utilized as one electron 
redox mediator in the field of artificial photosynthesis.15 Using metal-free porphyrin as 
an organocatalyst, more efficient C-H arylation of coumarins should be achieved under 
environmentally benign and mild reaction conditions.16 
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2-3. Reaction development 
 
  In order to evaluate the validity of my hypothesis, I started the initial reaction 
development as is shown in Scheme 10. In the presence of catalytic amounts of 
porphyrin derivatives 4a-4f, C(3)-H arylation of coumarin 1a was attempted using 
4-methoxybenzenediazonium tetrafluoroborate 2a. Although porphyrins with phenyl 
(4a) or 4-methoxyphenyl (4b) substituents did not afford the desired product (Scheme 10, 
entries 1-2), the coupling product was obtained in 17% yield in the presence of the 
porphyrin with 4-aminophenyl group 4c (entry 3). Evaluation of other porphyrins with 
different nitrogen substituent (4d, 4e, 4f) revealed that 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin 4e possessed the highest reactivity 
for the Meerwein-type arylation (entries 4-6). The low reactivity of 4d could be derived 
from its low solubility in DMSO solvent.17  
 
 
Scheme 10. Evaluation of porphyrin derivatives for C-H arylation of coumarin 
 
Encouraged by the result, optimization of the reaction conditions was performed 
(Scheme 11). When the reaction was run under dark conditions, the yield of the product 
did not change significantly, suggesting the thermal reaction pathway (Scheme 11, 
entry 2). The optimal amount of the porphyrin additive was determined to be 10 mol% 
(entries 1, 3-4) and the highest yield of the product was observed when the reaction 
temperature was raised to 40 °C, affording the desired product in 63% isolated yield 
(entry 5). As for control experiments, reactions without 4e or with catalytic amounts of 
N,N-diethylaniline (partial structure of 4e) was performed (entries 6-7). In either case, 
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no product formation was observed. These results imply that porphyrin skeleton is 
indispensable for the Meerwein-type arylation.  
 
 
Scheme 11. Optimization of the porphyrin-mediated C(3)-H arylation of coumarin 
 
  In order to evaluate the efficiency of C-H arylation by 4e, C(3)-H arylation of 
coumarin was investigated using reported metal-free Meerwein-type arylation methods 
(Scheme 12). As a result, catalytic amounts of 4e produced the desired product in higher 
yield compared to all the investigated methods (Scheme 12, entries 1-5). These results 
support that 4e is the most effective organic promoter for the C(3)-H arylation of 
coumarins.18 
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Scheme 12. Evaluation of other metal-free C-H arylation methods 
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2-4. Substrate scope study 
 
2-4-1. Scope of coumarins 
 
  With the optimized reaction conditions, substrate scope of the Meerwein-type 
arylation in terms of coumarins was evaluated (Scheme 13). Unsubstituted and 
6-methyl coumarins were arylated in good yield (Scheme 13, entries 1-2). 6-Alkoxy 
substituted coumarins afforded the desired products in the highest yield (entries 3-4). 
Unprotected hydroxy group and diethylamino group were tolerated in the reaction 
conditions (entries 5-6). However, electron withdrawing nitro group on 6 position of the 
coumarin suppressed the C-C bond formation (entry 7). Amide substituted coumarin 
was arylated in good yield in spite of the relatively low amount (2.5 eq.) of the coumarin 
coupling partner (entry 8). 4-Substituted coumarins were arylated in good yield in spite 
of the steric demands (entries 9-10). These results suggest that the present metal-free 
arylation method is generally applicable to a series of coumarin derivatives. 
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Scheme 13. Scope of coumarin derivatives 
 
2-4-2. Scope of aryldiazonium salts 
 
  Substrate scope in terms of aryldiazonium tetrafluoroborate was also investigated 
(Scheme 14). Unsubstituted (Scheme 14, etnry 1), methyl (entry 2), or 
halogen-substituted (entries 3-6) aryldizonium salts produced the product in moderate 
to good yield. It is noteworthy that the 4-bromo and 4-iodo substituted aryldiaznonium 
salts were applicable to the C-H arylation because these aryl groups cannot be readily 
installed by palladium-catalyzed C-H arylation. Electron withdrawing functionalities 
such as ethyl ester (entry 7), trifluoromethyl (entry 8) made minor differences in 
reactivity. 4-Nitrobenzenediazonium tetrafluoroborate (entry 9) afforded the product in 
lower yield, possibly because reoxidation of the benzyl radical intermediate could be 
hampered by its strong electron withdrawing effect (vide infra). Ortho- and meta- 
substituted diazonium salts can be employed in the reaction (entries 10-11), although 
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the products were obtained in slightly lower yield. Together with the results of the 
substrate scope on coumarins, these results support that porphyrin-mediated sp2 C-H 
arylation method is highly versatile for the preparation of C(3)-substituted coumarins.  
 
 
Scheme 14. Scope of aryldiazonium tetrafluoroborates 
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2-5. Mechanistic discussions 
 
2-5-1. Detection of aryl radical by TEMPO trapping experiments 
 
  It is widely accepted that transition metal catalyzed Meerwein arylation of coumarins 
proceeds via aryl radical. In order to confirm the presence of aryl radical in the present 
reaction, TEMPO trapping experiment was performed (Scheme 15). In the presence of 
10 mol% of 4e, aryldiazonium tetrafluoroborate (1 eq.), coumarin (1eq.), and TEMPO (2 
eq.) was mixed. After 20 hours, no C-C bond formation was observed in all the cases. 
Instead, TEMPO trapped products were obtained from 4-nitrobenzenediazonium, 
4-ethoxycarbonylbenzenediazonium or phenyldiazonium salts. These results support 
that aryl radical is generated in the present reaction conditions. Isolation of the TEMPO 
trapped product from 4-methoxybenzenediazonium tetrafluoroborate was not successful 
by several purification procedures possibly because of the instability of the electron rich 
aromatic product. Nevertheless, generation of aryl radical from 
4-methoxybenzenediazonium tetrafluoroborate was indirectly confirmed by the radical 
clock experiment (vide infra). 
 
 
Scheme 15. Detection of aryl radical by the TEMPO trapping experiment 
 
2-5-2. Detection of benzyl radical by radical clock experiment 
 
 Following the confirmation of aryl radical intermediate, radical clock experiment was 
performed in order to confirm the presence of benzyl radical intermediate (Scheme 16). 
Using 4-cyclopropylcoumarin, C(3)-H arylation was attempted using 10 mol% of 4e and 
4-methoxybenzenediazonium tetrafluoroborate. After 11 hours, consumption of 
3-cyclopropylcoumarin and complexation of the reaction was observed. However, 
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3-aryl-4-allylcoumarin was isolated from the crude mixture in 7% yield. The ring 
opening of the cyclopropane indicated the presence of benzyl radical intermediate, 
which was produced by the addition of 4-methoxyphenyl radical to the C(3) position of 
the coumarin.  
 
 
Scheme 16. Detection of benzyl radical intermediate by the radical clock experiment 
 
2-5-3. Inductively coupled plasma (ICP) analysis 
 
  In order to evaluate the metal contamination in the porphyrin 4e, inductively coupled 
plasma (ICP) analysis was performed. Using ICP analysis, quantification of elements in 
the sample is possible. After the ICP analysis, it was revealed that amount of iron, 
copper, titanium (a potential catalyst for Meerwein arylation) and palladium (a 
potential catalyst for Heck-type arylation) were all below the detection limit (Scheme 
17). These results support that the present reaction is not catalyzed by transition metal 
impurities. 
 
 
Scheme 17. Quantification of metal contamination in 4e by ICP analysis 
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2-5-4. Plausible reaction mechanisms 
 
  Based on the experimental findings, a plausible reaction mechanism for the 
porphyrin-mediated C-H arylation of coumarins is shown in Scheme 18. One electron 
reduction of aryldiazonium tetrafluoroborate by the porphyrin produces aryl radical 5 
and nitrogen gas. The addition of aryl radical to the 3 position of coumarin affords 
benzyl radical intermediate 6. The benzyl radical intermediate is then oxidized by 
porphyrin radical cation, leading to the formation of C(3)-arylated coumarin and 
regeneration of the porphyrin catalyst. This reoxidation of 6 could be difficult when 
electron withdrawing functional groups are present either on coumarin or on 
aryldiazonium salt, resulting in the lower yield of nitro group containing products 
(Scheme 13, entry 7 and Scheme 14, entry 9). Oxidation of 6 could be also possible with 
another molecule of aryldiazonium tetrafluoroborate. 
 
 
Scheme 18. Plausible reaction mechanisms 
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2-6. Conclusions 
 
  In the first part of my Ph.D. study, I have disclosed that metal-free porphyrin, 
especially 5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin 4e, works as a novel 
redox active organocatalyst for the selective sp2 C-H arylation of coumarins. The 
porphyrin catalysis provides superior method for the Meerwein-type C-H arylation 
compared to conventional transition-metal-mediated or metal-free approaches, 
affording a variety of 3-arylcoumarins in synthetically useful yields.19. It is expected 
that the present reaction contributes not only to the discovery of new coumarin 
analogues in chemical sciences but also to the development of a new class of 
organocatalytic C-H functionalization reactions.20 Investigations toward more precise 
understanding of reaction mechanisms and application of this catalytic reaction to 
substrates other than coumarin21 are in progress. 
 
 
Scheme 19. Metal-free C(3)-H arylation of coumarins promoted by 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin19 
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3. Tris(pentafluorophenyl)borane-catalyzed acceptorless 
dehydrogenation of N-heterocycles 
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3-1. Research background 
 
3-1-1. N-Heteroarenes in pharmaceuticals 
 
  Nitrogen containing N-heteroarenes have long been of primary interest in synthetic 
organic chemistry. For example, a quinoline derivative bedaquiline is an antitubercular 
drug which is effective for the multidrug resistant tuberculosis.1 Quinine is also a 
quinoline derived pharmaceutical which has long been utilized for the treatment of 
malaria. Celecoxib, with pyrazole structure in its skeleton, is a newly developed 
anti-inflammatory agent which has reduced side effects compared to classical 
nonsteroidal anti-inflammatory drugs.2 A benzothiazole derivative riluzole is the first 
approved drug for treatment of amyotrophic lateral sclerosis (ALS).3 Due to the 
significant importance of these N-heteroarenes in medicinal chemistry, development of 
a new and efficient method for the preparation of this compound class is a central 
research theme in modern synthetic chemistry.  
 
 
Scheme 20. N-Heteroarenes in pharmaceuticals 
 
3-1-2. Catalytic dehydrogenation of N-heterocycles 
 
  Recently, catalytic dehydrogenation of (partially) saturated N-heterocycles via sp3 
C-H functionalization has emerged as a new and atom economical4 tool for the 
preparation of N-heteroarenes.5 Among all, aerobic dehydrogenation and acceptorless 
dehydrogenation are typically attractive in terms of environmental friendliness.  
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3-1-2-1. Aerobic dehydrogenation of N-heterocycles 
 
  Catalytic aerobic dehydrogenation of saturated N-heterocycles is more 
environmentally benign than the dehydrogenation mediated by stoichiometric chemical 
oxidants, because molecular oxygen is abundant and only harmless water is produced 
as a byproduct.6 There are several transition-metal-catalyzed methods,6a-6e, 6g-6i while 
more desirable transition-metal-free catalytic methods remain rare. For example of 
transition-metal-free dehydrogenation catalysis, Stahl reported aerobic 
dehydrogenation of saturated N-heterocycles using ZnI2/phd (phd = 
1,10-phenanthroline-5,6-dione) system (Scheme 21).6d  
 
 
Scheme 21. Aerobic dehydrogenation of N-heterocycles by ZnI2/phd6d 
 
This system can be characterized as biomimetic catalysis because the reaction 
mechanisms of the catalytic system are similar to that of quinone mediated 
dehydrogenation by copper amine oxidase enzymes (Scheme 22). After comprehensive 
mechanistic studies, Stahl proposed that secondary amines are dehydrogenated by 
quinone/hydroquinone redox cycle through hemiaminal intermediate, while the 
iodine/iodide redox cycle reoxidizes the hydroquinone and regenerate the quinone 
catalyst. Finally, molecular oxygen works as a terminal oxidant and reoxidizes iodide. 
This ZnI2/phd system is applicable for the dehydrogenation of secondary amines, and 
successfully applied to the aerobic dehydrogenation of 1,2,3,4-tetrahydroquinazolines 
and indolines. On the other hand, dehydrogenation of 1,2,3,4-tetrahydroquinoline was 
unsuccessful under this catalytic conditions.  
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Scheme 22. Reaction mechanisms of the dehydrogenation by ZnI2/phd 
 
Soon after, Stahl disclosed [Ru(phd)3]2+/Co(salophen) catalytic system for the aerobic 
dehydrogenation of 1,2,3,4-tetrahydroquinolines (Scheme 23).6g It is reported that 
utilization of ruthenium instead of zinc facilitates the more efficient dehydrogenation. 
However, requirements for the precious and toxic ruthenium is disadvantageous 
compared to transition-metal-free methods. 
 
 
Scheme 23. Aerobic dehydrogenation of tetrahydroquinolines by  
[Ru(phd)3]2+/Co(salophen)6g 
 
3-1-2-2. Acceptorless dehydrogenation of N-heterocycles 
 
  Catalytic acceptorless dehydrogenation can be considered to be an ideal way to 
desaturate organic compounds because no external reagent is necessary and valuable 
molecular hydrogen is expelled during the desaturation.7 Historically, synthetically 
relevant conditions were accomplished by homogeneous transition metal catalysts.8-9 
Yamaguchi and Fujita are the pioneers in this class of reactions, and first reported the 
acceptorless dehydrogenation of 1,2,3,4-tetrahydroquinolines by 
[IrCp*(2-hydroxypyridine)] catalyst (Scheme 24).9a The following computational study 
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suggested that 2-hydroxypyridine ligand assists deprotonation of amines while iridium 
center abstracts hydride from sp3 C-H bonds alpha to nitrogen atom. The subsequent 
protonolysis of iridium-hydride by 2-hydroxypyridine allows the release of molecular 
hydrogen and regeneration of the catalyst (Scheme 25).9h 
 
 
Scheme 24. Acceptorless dehydrogenation of tetrahydroquinolines by 
[IrCp*(2-hydroxypyridine)] catalyst9a 
 
 
Scheme 25. Proposed mechanisms of acceptorless dehydrogenation by 
[IrCp*(2-hydroxypyridine)] catalyst9h 
 
 Following this report, Xiao9b,g and Crabtree9e also developed iridium-catalyzed 
acceptorless dehydrogenations of saturated N-heterocycles. However, necessity for 
costly iridium is a common drawback of these precedents. Interestingly, Jones reported 
relevant acceptorless dehydrogenation reactions by iron9d or cobalt9f catalysis (Scheme 
26). Although the relative abundance of these first row transition metals could be an 
advantage, substrate scope and functional group tolerance of these catalytic systems 
has not been thoroughly investigated so far. 
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Scheme 26. Iron-catalyzed acceptorless dehydrogenation of N-heterocycles9d 
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3-2. Reaction design 
 
In order to establish a more synthetically-benign catalyst for acceptorless 
dehydrogenation of N-heterocycles, I focused on the chemistry of electrophilic 
organoboranes.10 Electrophilic organoboranes are common cocatalysts for olefin 
polymerization, and investigation of their chemical behavior has long been of interest in 
a field of inorganic chemistry. In early 2000s, Basset was working on the mechanistic 
investigations of olefin polymerization catalysts by means of multinuclear NMR 
analysis. In one of his publications, he described a unique reactivity of an electrophilic 
organoborane. It was reported that tris(pentafluorophenyl)borane abstracted hydride 
from sp3 C-H bonds of dialkylanilines, and reversibly formed iminium-borohydride 
complex (Scheme 27).11a 
 
 
Scheme 27. Hydride abstraction from sp3 C-H bonds of amines by an electrophilic  
organoborane11a 
 
Based on this discovery, I hypothesized that novel catalytic acceptorless 
dehydrogenation could be realized as described in Scheme 28. First, hydride 
abstraction11 from sp3 C-H bonds of amines by an electrophilic borane produces 
iminium-borohydride complex. Second, protonolysis of the borohydride produces the 
desaturated amines and releases molecular hydrogen, regenerating the oraganoborane 
catalyst.12-13 
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Scheme 28. Reaction design 
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3-3. Reaction development 
 
  In order to evaluate the validity of my hypothesis, catalytic acceptorless 
dehydrogenation of 2-methyl-1,2,3,4-tetrahydroquinoline 2a was investigated in the 
presence of catalytic amounts of electrophilic organoboranes 1 (Scheme 29). Gratifyingly, 
desired product 3a was obtained in 42% yield with 2.5 mol% of 
tris(pentafluorophenyl)borane 1a (Scheme 29, entry 1). Fluoroarylboranes 1c or 1d with 
reduced Lewis acidity compared to tris(pentafluorophenyl)borane resulted in low 
activity (entries 2-3). Phosphinoborane 1e, which has comparable Lewis acidity 
compared to tris(pentafluorophenyl)borane afforded 3a in modest yield (entry 4). More 
Lewis acidic phosphonium borane 1f or chloroaryl boranes 1g, 1h showed almost no 
reactivity (entries 5-7). From these results, tris(pentafluorophenyl)borane 1a was 
identified as the most reactive catalyst for the catalytic dehydrogenation. 
  Lewis basic additives 1i and 1j made no positive effects for the transformation 
(entries 8-9). Survey of the reaction temperature revealed that the highest yield (92%) 
was obtained when the reaction was run at 150 °C (entry 10), while catalytic 
dehydrogenation under lower temperature resulted in limited success (entries 11-12). 
From these observations, I have identified that the conditions of entry 10 is optimal for 
the borane-catalyzed acceptorless dehydrogenation of 1,2,3,4-tetrahydroquinoline 
derivatives. 
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2a (0.25 mmol) and the catalyst were dissolved in p-xylene (0.5 mL) and heated in a 
screw-capped tube (diameter = 25 mm, height = 200 mm) for 22 hours. a 1H NMR yield. b 
Isolated yield. 
 
Scheme 29. Optimization of reaction conditions 
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3-4. Substrate scope study 
 
3-4-1. Quinoline derivatives 
 
  With the optimized conditions in hand, substrate scope of the borane-catalyzed 
dehydrogenation for the synthesis of quinoline derivatives has been investigated 
(Scheme 30). For the substituent of the 2-position of quinolines, methyl, butyl, and aryl 
groups were tolerated (Scheme 30, entries 1-3). As for functional groups on 2-aryl rings, 
electron donating methyl and withdrawing chloro group made minor differences in the 
catalytic activity (entries 4-5). It is worthwhile to note that thioether group, which could 
be sensitive to the common oxidative reaction conditions, was compatible in the 
standard conditions (entry 6). Functional groups on 6-position of quinolines such as 
methyl, methoxy, fluoro, chloro and bromo were all compatible in the dehydrogenation 
reaction (entries 7-11). The relatively lower yield of the methoxy substituted quinoline 
could be due to catalyst deactivation by strong coordination of oxygen to the borane 
(entry 2h). 8-Substituted quinolines could also be synthesized from the respective 
tetrahydroquinoline in good yield under relevant conditions (entries 12-13). These 
results prove that the borane-catalyzed dehydrogenation is highly general for the 
preparation of the substituted quinoline derivatives. 
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a 10 mol% of 1a was used. 
 
Scheme 30. Scope of 1,2,3,4-tetrahydroquinoline derivatives 
 
3-4-1. Other N-heterocycles 
 
  Encouraged by these results, substrate scope of other N-heterocycles was investigated 
(Scheme 31). Qunoxalines are important N-heteroarenes in medicinal chemistry,14 and 
their synthesis by catalytic dehydrogenation would be beneficial for the preparation of 
these N-heteroarenes. Using the optimal conditions for the quinoline synthesis, 
tetrahydroquinoxalines with methyl or phenyl group on 2,3-positions were 
dehydrogenated in good yield (Scheme 31, entries 1-2). Considering that there are 
several established methods for the synthesis of indolines,15 catalytic dehydrogenation 
of indolines should provide reliable synthetic routes to indoles. While catalytic 
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dehydrogenation of an unsubstituted indoline produced the desired product in modest 
yield even after prolonged reaction time (entry 3), 2-methylindole and N-methylindole 
were synthetized in excellent yield under standard conditions from the respective 
indolines (entries 4-5). It is worthwhile to note that 3r was successfully dehydrogenated 
under the borane catalysis because 2r was not dehydrogenated in good yield by the 
transition-metal-free aerobic dehydrogenation conditions.6d Pyrazoles are usually 
synthesized by the dehydrogenation of pyrazolines, which are readily synthesized from 
the condensation of enone and hydrazine. With 5 mol% or 10 mol% of the borane 
catalyst, pyrazoles were synthesized from the respective pyrazolines in good to excellent 
yield (entries 6-7). The modest reactivity of 2s could be due to the limited catalyst 
turnovers by strong coordination of its nitrogen lone pair of the product 3s to the borane. 
Benzothiazoles are another ubiquitous N-heteroarenes in medicinal chemistry. 
Nevertheless, catalytic acceptorless dehydrogenation of benzothiazolines by 
homogeneous metal catalysts is especially challenging because the sulfur atom works as 
a catalyst poison. However, with 10 mol% of the borane catalyst, benzothiazoles were 
synthesized in good to excellent yield by the catalytic dehydrogenation of 
benzothiazolines (entries 8-10).   
 
38 
 
 
a 10 mol% of 1a was used. b The reaction was run for 48 hours. 
 
Scheme 31. Scope of other N-heterocycles 
 
3-4-2. Current limitations 
 
3-4-2-1. Tolerance to other oxygen functionalities 
 
  Some partially saturated N-heterocycles were not effectively dehydrogenated in the 
present catalytic conditions. For example, when 1,2,3,4-tetrahydroquinoline derivatives 
with alcohol S2a was subjected to standard dehydrogenation conditions, significant 
decomposition of starting material was observed, and no desired product S3b was 
obtained (Scheme 32, upper row). On the other hand, when 1,2,3,4-tetrahydroquinoline 
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S2b with an ester functionality was subjected to dehydrogenation in the presence of 10 
mol% of B(C6F5)3, formation of quinoline ester S3b was observed only in a trace amount 
(Scheme 32, middle row). In addition, when substrate S2c was subjected to standard 
dehydrogenation conditions, only decomposition of S2c was observed, possibly due to the 
limited stability of the furyl group under the reaction conditions (Scheme 32, lower row). 
Thus, the limited tolerance to benzyl alcohol, ester, or 5-membered oxygen heterocycle is 
limitation of the present protocol. 
 
 
Scheme 32. Borane-catalyzed dehydrogenation of oxygen containing substrates 
 
3-4-2-2. Dehydrogenation of piperidine derivatives 
 
  Stephan and Crudden reported hydride abstraction from Hantzsch ester derivatives 
by tris(pentafluorophenyl)borane in a stoichiometric fashion.16 Thus, we evaluated 
whether the dehydrogenation of piperidine derivatives could take place under the 
present reaction conditions (Scheme 33).  Three kinds of N-phenyl piperidine 
derivatives S2d, S2e, and S2f were subjected to the catalytic dehydrogenation in the 
presence of 10 mol% borane catalyst under 180 °C. However, no dehydrogenated 
products were obtained from any of these cyclic amines, and the starting materials were 
recovered. These results indicate the limited applicability of our protocol for the 
dehydrogenation of 1-phenylpiperidine derivatives. 
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Scheme 33. Borane-catalyzed dehydrogenation of N-phenylpiperidine derivatives 
 
3-4-2-3. Dehydrogenation of 1-methyl-1,2,3,4-tetrahydroisoquinoline 
 
  Catalytic dehydrogenation of 2-methyl-1,2,3,4-tetrahydroisoquinoine S2g was also 
tried since isoquinolines are an important class of N-heterocycles in organic synthesis 
(Scheme 34). However, even at 180 °C in the presence of 10 mol% of the borane catalyst, 
only very small conversion to isoquinoline was observed. We tentatively assume that 
strong coordination of tetrahydroisoquinoline or isoquinoline to 
tris(pentafluorophenyl)borane might inhibit efficient catalytic turnovers.  
 
 
Scheme 34. Borane-catalyzed dehydrogenation of tetrahydroisoquinoline 
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3-5. Comparison of reactivity 
 
  The high reactivity of the borane catalyst for the dehydrogenation of a 
benzothiazoline 2w (Scheme 35, entry 1) suggests that the borane catalyst should have 
high compatibility to sulfur containing compounds compared to metal-based 
dehydrogenation catalysis. In order to prove the hypothesis, catalytic acceptorless 
dehydrogenation of 2w by Cp*Ir(2-hydroxypyridine)9a was attempted with 10 mol% of 
the iridium catalyst. As a result, the desired product 3w was obtained in 38% yield 
(entry 2). On the other hand, transition-metal-free aerobic oxidation of 2w by ZnI2/phd 
catalyst6d afforded 3w in 7% yield (entry 3). These results suggest that 
tris(pentafluorophenyl)borane has a uniquely high tolerance toward sulfur 
functionalities compared to the metal-catalyzed counterparts. 
 
 
Scheme 35. Comparison of dehydrogenation reactivity  
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3-6. Application study 
 
  In order to evaluate the synthetic utility of the present reaction, the borane-catalyzed 
dehydrogenation was applied to the synthesis of a functional molecule (Scheme 36). 
Tobita reported that iridium complex 5 worked as a mitochondria-targeted oxygen probe 
in HeLa cells.17 The heterobiaryl 3x is a precursor for 5, and was previously synthesized 
by palladium-catalyzed Suzuki-Miyaura coupling. I envisioned that 3x could be 
synthesized by the catalytic dehydrogenation of a respective partially saturated 
N-heterocycle 2x. According to the method by Miyata,18 treatment of readily available 
hydroxylamine methyl ether 4 with organolithium reagent afforded 2x in 78% yield. 
Then, catalytic dehydrogenation of 2x by B(C6F5)3 proceeded smoothly, and 3x was 
obtained in quantitative yield. For the preparation of synthetic drugs or probe 
molecules for chemical biology, contamination of toxic transition metal is a severe 
problem. In that sense, these transition metal free transformations should constitute a 
valuable new method for the preparation of 2-subsituted quinolines not only for 
materials science but also for synthesis of biologically active substances. 
 
 
Scheme 36. Transition metal free synthesis of heterobiaryl 3x 
  
43 
 
3-7. Mechanistic discussions 
 
3-7-1. Confirmation of hydride abstraction by NMR study 
 
According to the precedential reports,11a,11h tris(pentafluorophenyl)borane 1a can 
reversibly abstract hydride from sp3 C-H bonds of saturated amines (Scheme 37, upper 
row). Based on these literature precedents, it is expected that 1a would abstract hydride 
from cyclic amine 2a and form the iminium-borohydride complex, whose 19F NMR 
resonances are expected to be similar to the reported values of iminium-borohydride 
complex (δ = 133, 162, 165 ppm). Indeed, in the NMR analysis of the mixture of 
2-methyl-1,2,3,4-tetrahydroquinoline 2a and tris(pentafluorophenyl)borane 1a in 
toluene-d8, the relevant 19F NMR resonances (δ = 136, 160, 165 ppm) were observed 
(Scheme 37, lower row). Since chemical shifts and relative integrations of the signals 
observed in the NMR experiment were in good agreement with the literature values,11a 
these results support that iminium-borohydride intermediate is formed from 2a and 1a 
in the reaction mixture. 
 
 
Scheme 37. Comparison between the reported and our NMR studies 
 
3-7-2. Confirmation of H2 gas release by dual reactions 
 
  In order to confirm that molecular hydrogen is expelled during the desaturation of 
N-heterocycles, a dual reactions experiment was conducted (Scheme 38). In one side of a 
COware (Scheme 39), a two-chamber reaction vessel, 
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2-methyl-1,2,3,4-tetrahydroquinoline 2a and catalytic amounts of 
tris(pentafluorophenyl)borane 1a was dissolved in p-xylene. In the other side of the 
apparatus, benzene solution of cyclododecene 6 and Wilkinson’s catalyst was placed. 
These two reactions share the same atmosphere and only gaseous components can be 
transferred to the other side of the reaction. After 48 hours of the reaction, 
2-methylquinoline 3a was obtained in 78% yield and cyclododecane 7 was obtained in 
66% yield, respectively. Formation of 7 clearly indicates the release of H2 during the 
desaturation of 2a, which was transferred to the other side of the apparatus and utilized 
in rhodium-catalyzed hydrogenation of 6. 
 
 
Scheme 38. Confirmation of the release of gaseous H2 via a dual reaction 
 
 
Scheme 39. Appearance of COware 
 
3-7-3. Plausible catalytic cycle for dehydrogenation of 1,2,3,4-tetrahydroquinolines 
 
  Based on the NMR studies, it is reasonable to assume that the present 
dehydrogenation reaction proceeds via borohydride intermediate. Evolution of gaseous 
hydrogen was also confirmed by the dual reactions experiment. Supported by these 
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experimental results, a plausible catalytic cycle is suggested as shown in Scheme 40. 
Electrophilic borane 1a abstracts hydride from sp3 C-H bond alpha to the nitrogen atom 
of substrates 2, and forms borohydride-iminium complex A. Protonolysis of the complex 
releases partially desaturated N-heterocycle B along with molecular hydrogen and 
regenerates the borane catalyst. It is reported that 3,4-dihydroquinoline undergoes 
disproportionation into quinoline 3 and 1,2,3,4-tetrahydroquinoline under acidic 
conditions.19 Since the borane works as a Lewis acid, this process may be also 
accelerated by 1a. The overall catalytic process could be hampered when a substrate 
forms a stable Lewis adduct with 1a and deactivates the borane catalyst, leading to the 
limited reactivity of 1,2,3,4-tetrahydroisoquinoline S2g. 
 
 
Scheme 40. Plausible catalytic cycle 
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3-8. Conclusion 
 
  In conclusion, tris(pentafluorophenyl)borane 1a realized the first metal-free 
acceptorless dehydrogenation of N-heterocycles (Scheme 41). The scope of the 
borane-catalyzed acceptorless dehydrogenation is quite broad, and several kinds of 
synthetically valuable N-heteroarenes were produced in up to quantitative yield. The 
present borane catalysis exhibited high tolerance to sulfur functionalities, and 
demonstrated superior reactivity for the dehydrogenative synthesis of benzothiazole 
compared to conventional metal-catalyzed dehydrogenation methods. Considering the 
abundance and inherently low toxicity of boron compared to transition metals,20 the 
present boron catalysis provides explicit advantages compared to metal-catalyzed 
systems.21 Thus, the present catalytic reaction demonstrates a new way of utilizing 
organoboranes in synthetic organic chemistry. Application of the borane catalysis to 
other types of sp3 C-H functionalizations is currently in progress. 
 
 
Scheme 41. Tris(pentafluorophenyl)borane-catalyzed acceptorless dehydrogenation of 
N-heterocycles 
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1. General Method 
1H NMR spectra were recorded on JEOL ECX500 (500 MHz for 1H NMR and 125.65 
MHz for 13C NMR), and JEOL ECS400 (400 MHz for 1H NMR, 100 MHz for 13C NMR 
and 368 MHz for 19F NMR) spectrometer.  For 1H NMR and 13C NMR, chemical shifts 
were reported in the scale relative to the solvent used as an internal reference.  For 19F 
NMR, chemical shifts were reported relative to hexafluorobenzene (δ = 164.90 ppm) as 
an external reference.  Electrospray ionization (ESI)-mass spectra were measured on a 
JEOL JMS-T100LC AccuTOF spectrometer for HRMS.  Infrared (IR) spectra were 
recorded on a JASCO FT/IR 410 Fourier transform infrared spectrophotometer.  
Microwave irradiation was performed with Biotage Initiator.  ICP analysis was 
conducted with Shimadzu ICPS-7510.  Column chromatographies were performed with 
silica gel Merck 60 (230-400 mesh ASTM).  Gel permeation chromatography (GPC) 
purification was conducted on a Japan Analytical Industry Co., Ltd. LC9210NEXT 
equipped with JAIGEL-1H and JAIGEL-2H, and CHCl3 was used as an eluent.  All 
non-commercially available compounds were prepared and characterized as described 
in Section 5 of this experimental section.  Other reagents were purchased from Aldrich, 
Tokyo Chemical Industry Co., Ltd. (TCI), Kanto Chemical Co., Inc., and Wako Pure 
Chemical Industries, Ltd. and were used as received.  
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2. General Procedure for the Arylation of Coumarins 
 
4-Fluorobenzenediazonium tetrafluoroborate (2d) (52.5 mg, 0.25 mmol), 
7-ethoxycoumarin (1d) (238 mg, 1.25 mmol) and 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin (4e) (22.5 mg, 0.025 mmol) were 
added in a dry test tube under argon atmosphere.  Degassed DMSO (0.5 mL) was 
added into the tube, and the reaction mixture was stirred for 16 hours at 40 °C.  After 
cooling the reaction to room temperature, the mixture was absorbed in silica gel and 
subjected to column chromatography (EtOAc/n-hexane = 2/13), which afforded pure 3m 
(47.9 mg, 0.169 mmol) in 67% yield as white solid.  
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3. Mechanistic Studies 
a) Details of the aryl radical trapping experiment 
Considering that Meerwein arylation proceeds via an aryl radical intermediate, an 
aryl radical trapping experiment was performed in order to see whether aryl radicals 
involve in the present reaction (Scheme S1). 
 
 
Scheme S1. Detection of an aryl radical intermediate 
 
To a stirred solution of TEMPO (6.2 mg, 0.040 mmol), coumarin (29.2 mg, 0.20 mmol) 
and 4e (18.0 mg, 0.020 mmol) in DMSO (1.0 mL) was added a solution of aryldiazonium 
tetrafluoroborate (0.20 mmol) in DMSO (1.0 mL).  After 20 hours, water (20 mL) was 
added, and products were extracted with EtOAc (20 mL x 3). The combined organic 
layer was dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude product was purified by column chromatography. Attempts to isolate 7d with 
column chromatography (with SiO2, neutral silica or alumina) or GPC were 
unsuccessful possibly because of facile decomposition of 7d. 3-Arylcoumarins were not 
observed in all the cases. The efficient TEMPO-trapping as well as the absence of 
3-arylcoumarin products support that aryl radicals are the key intermediate for the 
present C-C bond formation.  
 
2,2,6,6-tetramethyl-1-(4-nitrophenoxy)piperidine (7a) 
 NMR spectra of the obtained product were consistent with the 
reported one.1 
 
4-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)benzoate (7b) 
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 1H NMR (CDCl3): δ = 7.91 (2H, d, J = 9.2 Hz), 7.19 (2H, s), 4.31 
(2H, q, J = 7.2 Hz), 1.67-1.54 (6H, m), 1.34 (3H, t, J = 7.2 Hz), 1.21 (6H, s), 0.97 (6H, s); 
13C NMR (CDCl3): δ = 167.38, 166.56, 130.99, 122.31, 113.69, 60.56, 60.42, 39.67, 32.35, 
20.42, 16.95, 14.41; HRMS (ESI): m/z calcd for C18H27NO3Na [M+Na]+ 328.1883 Found 
328.1885; IR (KBr): 2977, 2932, 1715, 1602, 1501, 1272, 1252, 1150, 1109, 1095 cm
-1 
 
2,2,6,6-tetramethyl-1-phenoxypiperidine (7c) 
 NMR spectra of the obtained product were consistent with the reported 
one.2 
 
b) Details of the benzyl radical detection experiment 
  Compound S1a was subjected to the reaction conditions in order to determine the 
presence of benzyl radical intermediate (Scheme S2). Based on a concept of “radical 
clock,”3a,3b cyclopropane opening should occur if benzyl radical intermediate was 
generated. As the observed product S3a is formed through ring-opening of cyclopropane, 
benzyl radical intermediate is likely to have involved in the present reaction.3c Product 
with the cyclopropane moiety remained (S3b) was not obtained. These results also 
indicate that 4-methoxybenzenediazonium tetrafluoroborate reacts via radical pathway. 
 
 
Scheme S2. A radical clock experiment 
 
4-methoxybenzenediazonium tetrafluoroborate (2a) (22.2 mg, 0.10 mmol), 
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4-cyclopropyl-2H-chromen-2-one (S1a) (18.6 mg, 0.10 mmol) and 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin (4e) (9.0 mg, 0.010 mmol) were 
added in a dry test tube under argon atmosphere.  Degassed DMSO (0.2 mL) was 
added into the tube, and the reaction mixture was stirred for 10 hours at 40 °C.  After 
cooling the reaction to room temperature, the mixture was absorbed in silica gel and 
subjected to column chromatography (EtOAc/n-hexane = 1/5) and then subjected to GPC, 
which afforded pure S3a (2.0 mg, 0.0068 mmol) in 7% yield as white solid. 
 
4-allyl-3-(4-methoxyphenyl)-2H-chromen-2-one (S3a) 
 1H NMR (CDCl3): δ = 7.65 (1H, dd, J = 7.4, 1.4 Hz), 7.50 (1H, dt, J 
= 7.9, 1.4 Hz), 7.36 (1H, dd, J = 8.2, 1.1 Hz), 7.29-7.23 (3H, m), 6.95 (2H, d, J = 9.0 Hz), 
5.93 (1H, m), 5.14 (1H, dd, J = 10.7, 1.4 Hz), 4.99 (1H, dd, J = 17.6, 1.2 Hz), 3.83 (3H, s), 
3.44 (2H, d, J = 5.7 Hz), ; 13C NMR (CDCl3): δ = 161.43, 159.58, 152.95, 148.46, 134.21, 
131.13, 130.81, 127.85, 126.27, 125.87, 124.15, 119.61, 117.85, 116.97, 113.87, 55.29, 
33.93; HRMS (ESI): m/z calcd for C19H16O3Na [M+Na]+ 315.0992 Found 315.0994; IR 
(KBr): 1711, 1595, 1509, 1449, 1248, 1164, 1148, 835 cm
-1 
 
c) Solubility measurement of 4d and 4e 
In order to rationalize the difference in reactivity between 4d and 4e, their solubility 
in DMSO was evaluated. To an Eppendorf tube, 4d or 4e (50 mg) and DMSO (1 mL) 
were added. The tube was subjected to vortex mixing for 5 minutes and centrifuged 
(100,000 rpm for 5 minutes). Then 0.1 mL of their supernatant was transferred to a 
glass vial, which was freezed with liquid nitrogen and dried under high vacuum. After 
the removal of solvent, solid from the supernatant of 4d weighed 0.33 mg whereas that 
from 4e weighed 4.10 mg. These results suggested that the solubility of 4d is 3.3 g/L (= 
4.2 mM) and 4e is 41.0 g/L (= 46 mM). Therefore, their maximum concentration in the 
standard reaction conditions (0.5 M to aryldiazonium tetrafluoroborate) corresponds to 
0.84 mol% for 4d and 9.2 mol% for 4e. This inherent difference in solubility could be one 
crucial factor for the catalytic reactivity. 
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4. Arylation of Other Substrate 
 
  Along with the study of the C(3)-H arylation of coumarins, Meerwein-type arylation of 
other substrates were investigated. As a preliminary result, it was confirmed that 
Meerwein arylation of furan with 4-bromobenzenediazonium tetrafluoroborate 2f 
occurred in the presence of 5 mol% of 5,10,15,20-tetrakis(4-aminophenyl)porphyrin 4c 
(Scheme S3). This result implies that catalytic activity of 
tetrakis(4-aminophenyl)porphyrin derivatives are not specific to the arylation of 
coumarins. Optimization of the reaction conditions and investigation of substrate scope 
are currently underway. 
 
 
Scheme S3.C-H Arylation of furan with 4c 
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5. Syntheses of Catalysts and Substrates 
a) Synthesis of 4e 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin (4e) 
 
4e can be synthesized as was reported previously.4  We also developed a new 
procedure for shorter reaction time and better reproducibility.  
4-Diethylaminobenzaldehyde (2.5 g, 14.1 mmol) and freshly distilled pyrrole (0.875 mL, 
12.6 mmol) were heated to 250 °C under microwave irradiation in a sealed tube for 12 
hours.  Then the reaction mixture was cooled to room temperature and was suspended 
into acetone (125 mL).  The suspension was filtered and washed several times with 
acetone.  The solid was dried under vacuum and pure 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin was obtained (206.7 mg, 0.230 
mmol) in 7% yield as black solid. 
 
5,10,15,20-tetrakis(4-diethylaminophenyl)porphyrin (4e) 
1H NMR (CDCl3): δ = 8.92 (8H, s), 8.08 (8H, d, J = 8.8 Hz), 
7.04 (8H, d, J = 9.1 Hz), 3.61 (16H, q, J = 7.1 Hz), 1.39 (24H, t, J = 7.1 Hz),  2.54 (2H, s); 
13C NMR (CDCl3): δ = 147.21, 136.15, 129.71, 128.90, 120.41, 110.01, 44.57, 12.86 (one 
aromatic carbon is overlapped or unidentified); HRMS (ESI): m/z calcd for C60H67N8 
[M+H]+ 899.5483 Found 899.5484; IR (KBr): 2968, 1606, 1519, 1353, 1265, 1194, 800 cm
-1
. 
 
b) Synthesis of aryldiazonium tetrafluoroborates 
  All the aryldiazonium tetrafluoroborates were synthesized according to the reported 
procedure.5 
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c) Synthesis of 1h 
N-(2-oxo-2H-chromen-6-yl)pivalamide (1h)  
 
6-Nitrocoumarin (1.91 g, 10 mmol) and SnCl2 (6.17 g, 33 mmol) were suspended in 
concentrated HCl (100 mL) and heated to 75 °C for 1 hour.  Then the reaction mixture 
was cooled to 0 °C on ice bath and basified with saturated NH3 aqueous solution (120 
mL).  The resulting suspension was filtered, washed with H2O and extracted with 
acetone.  Concentration of the acetone extract afforded 6-aminocoumarin (S2) (1.22 g, 
7.5 mmol) in 75% yield as yellow solid. 
 
6-aminocoumarin (S2) 
 NMR spectra of the obtained product were consistent with the 
reported one.6 
 
  A solution of 6-aminocoumarin (600 mg, 3.73 mmol) and Et3N (0.624 mL, 4.48 mmol) 
in CH2Cl2 (7.5 mL) were cooled to 0 °C and PivCl (0.483 mL, 3.92 mmol) was added 
dropwise.  The reaction mixture was warmed to room temperature and was stirred for 
3 hours.  Then the reaction mixture was washed with water three times.  The organic 
layer was dried with Na2SO4, filtered and concentrated to afford 
N-(2-oxo-2H-chromen-6-yl)pivalamide (1h) (815 mg, 3.07 mmol) in 82% yield as white 
solid. 
 
N-(2-oxo-2H-chromen-6-yl)pivalamide (1h) 
 1H NMR (CDCl3): δ = 8.04 (1H, d, J = 2.3 Hz), 7.65 (1H, d, J = 9.8 
Hz), 7.38 (1H, s), 7.37 (1H, dd, J = 8.9, 2.3 Hz), 7.26 (1H, d, J = 8.9 Hz), 6.41 (1H, d, J = 
9.8 Hz), 1.32 (9H, s); 13C NMR (CDCl3): δ = 177.03, 160.77, 150.24, 143.48, 134.62, 
123.90, 118.83, 118.76, 116.97, 116.93, 39.59, 27.46; HRMS (ESI): m/z calcd for 
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C18H18O2Na [M+Na]+ 268.0944 Found 268.0934; IR (KBr): 3262, 2984, 1735, 1650, 1573, 
1536, 1435, 1156, 822 cm
-1 
 
d) Synthesis of S1a 
4-cyclopropyl-2H-chromen-2-one (S1a)  
 
  To a flame-dried flask was added ZnCl2 (1M in diethyl ether: 4.0 mL, 4.0 mmol) and 
cyclopropyl magnesium bromide (0.5 M in THF: 8.0 mL, 4.0 mmol). The resulting 
suspension was stirred at 50 °C for 40 minutes. The suspension was cooled to room 
temperature and its supernatant was used for the reaction. 
  2-oxo-2H-chromen-4-yl trifluoromethanesulfonate was prepared as reported 
previously.7 To a stirred suspension of Pd(PPh3)4 (46.0 mg, 0.040 mmol) and 
2-oxo-2H-chromen-4-yl trifluoromethanesulfonate (58.8 mg, 0.20 mmol) in dry THF (0.5 
mL), the supernatant (1.8 ml, 0.6 mmol of cyclopropyl zinc chloride) was added. The 
mixture was stirred at 50 °C for 11 hours. After cooling to room temperature, the 
reaction was quenched with 1N HCl. After extraction with EtOAc, the combined organic 
layer was dried over Na2SO4, filtered and concentrated under reduced pressure. 
Purification by column chromatography (EtOAc/n-hexane = 1/10 to 1/5) afforded 
4-cyclopropyl-2H-chromen-2-one (S1a) (15.2 mg, 0.082 mmol) in 41% yield as white 
solid.  
 
4-cyclopropyl-2H-chromen-2-one (S1a) 
 1H NMR (CDCl3): δ = 7.79 (1H, d, J = 8.6 Hz), 6.87 (1H, dd, J = 8.6, 2.6 Hz), 
6.80 (1H, d, J = 2.6 Hz), 5.87 (1H, s), 3.86 (3H, s), 2.08-2.02 (1H, m), 1.13-1.09 (1H,m), 
0.83-0.80 (1H, m); 13C NMR (CDCl3): δ = 161.44, 157.66, 153.37,131.62, 124.63, 124.12, 
120.17, 117.07, 110.33, 11.95, 8.01; HRMS (ESI): m/z calcd for C12H10O2Na [M+Na]+ 
209.0573 Found 209.0557; IR (KBr): 1719, 1609, 1408, 1281, 1208, 1137, 841 cm
-1 
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6. Characterization of Target Compounds 
3-(4-methoxyphenyl)-2H-chromen-2-one (3a) 
 NMR spectra of the obtained product were consistent with the 
reported one.8 
 
3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one (3b) 
 NMR spectra of the obtained product were consistent with 
the reported one.8 
 
7-methoxy-3-(4-methoxyphenyl)-2H-chromen-2-one (3c) 
 NMR spectra of the obtained product were consistent with 
the reported one.8 
 
7-ethoxy-3-(4-methoxyphenyl)-2H-chromen-2-one (3d) 
 NMR spectra of the obtained product were consistent with 
the reported one.8 
 
7-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one (3e) 
 NMR spectra of the obtained product were consistent with 
the reported one.9 
 
7-(diethylamino)-3-(4-methoxyphenyl)-2H-chromen-2-one (3f) 
 NMR spectra of the obtained product were consistent with 
the reported one.8 
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3-(4-methoxyphenyl)-6-nitro-2H-chromen-2-one (3g) 
 NMR spectra of the obtained product were consistent with 
the reported one.10 
 
N-(3-(4-methoxyphenyl)-2-oxo-2H-chromen-6-yl)pivalamide (3h) 
 1H NMR (CDCl3): δ = 8.05 (1H, d, J = 2.5 Hz), 7.68 (1H, s), 
7.63 (2H, d, J = 9.2 Hz), 7.44 (1H, s), 7.36 (1H, dd, J = 9.0, 2.5 Hz), 7.26 (1H, d, J = 8.9 
Hz), 6.95 (2H, d, J = 9.2 Hz), 3.83 (3H, s), 1.32 (9H, s); 13C NMR (CDCl3): δ = 176.85, 
160.72, 160.21, 149.69, 138.31, 134.46, 129.83, 128.31, 126.95, 122.97, 119.99, 118.51, 
116.59, 113.94, 55.35, 39.65, 27.57; HRMS (ESI): m/z calcd for C21H21NO4Na [M+Na]+ 
374.1363 Found 374.1363; IR (KBr): 3282, 2967, 1725, 1649, 1514, 1253, 826 cm
-1
 
 
7-(diethylamino)-3-(4-methoxyphenyl)-4-methyl-2H-chromen-2-one (3i) 
 1H NMR (CDCl3): δ = 7.42 (1H, d, J = 9.0 Hz), 7.20 (2H, d, J 
= 9.0 Hz), 6.94 (2H, d, J = 10 Hz), 6.59 (1H, dd, J = 9.0, 2.5 Hz), 6.52 (1H, d, J = 2.5 Hz), 
3.40 (4H, q, J = 7.2 Hz), 1.19 (6H, t, J = 7.0 Hz); 13C NMR (CDCl3): δ = 162.25, 158.87, 
154.91, 150.03, 148.06, 131.58, 127.44, 125.98, 120.65, 113.65, 109.53, 108.47, 97.39, 
55.20, 44.66, 16.26, 12.39; HRMS (ESI): m/z calcd for C21H23NO3Na [M+Na]+ 360.1570 
Found 360.1587; IR (KBr): 2966, 1703, 1617, 1578, 1524, 1273, 1248, 1073 cm
-1
 
 
4-hydroxy-3-(4-methoxyphenyl)-2H-chromen-2-one (3j) 
 NMR spectra of the obtained product were consistent with the 
reported one.11 
 
7-ethoxy-3-phenyl-2H-chromen-2-one (3k) 
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 1H NMR (CDCl3): δ = 7.73 (1H, s), 7.66 (2H, d, J = 7.1 Hz), 
7.43-7.33 (4H, m), 6.85-6.79 (2H, m), 4.08 (2H, q, J = 7.2 Hz), 1.44 (3H, t, J = 7.1 Hz); 13C 
NMR (CDCl3): δ = 161.97, 160.90, 155.28, 140.03, 135.03, 128.78, 128.37, 128.35, 124.61, 
113.17, 113.11, 100.83, 64.15, 14.53 (one carbon is overlapped); HRMS (ESI): m/z calcd 
for C17H14O3Na [M+Na]+ 289.0835 Found 289.0844; IR (KBr): 2977, 1711, 1604, 1274, 823, 
783, 692 cm
-1
 
 
7-ethoxy-3-(p-tolyl)-2H-chromen-2-one (3l) 
 1H NMR (CDCl3): δ = 7.70 (1H, s), 7.57 (2H, d, J = 8.2 Hz), 7.38 
(1H, d, J = 8.5 Hz), 7.22 (2H, d, J = 8.0 Hz), 6.82 (1H, dd, J = 8.5, 2.3 Hz), 6.81 (1H, d, J = 
2.5 Hz), 4.08 (2H, q, J = 7.1 Hz), 2.37 (3H, s), 1.44 (3H, t, J = 7.1 Hz); 13C NMR (CDCl3): δ 
= 161.81, 161.00, 155.17, 139.40, 138.34, 132.13, 129.08, 128.66, 128.22, 124.62, 113.27, 
113.04, 100.82, 64.13, 21.22, 14.54; HRMS (ESI): m/z calcd for C18H16O3Na [M+Na]+ 
303.0992 Found 303.0994; IR (KBr): 1704, 1606, 1268, 1180, 1123, 1038, 822 cm
-1
 
 
7-ethoxy-3-(4-fluorophenyl)-2H-chromen-2-one (3m)  
 1H NMR (CDCl3): δ = 7.70 (1H, s), 7.64 (2H, dd, J = 9.2, 5.5 Hz), 
7.39 (1H, d, J = 8.7 Hz), 7.09 (2H, dd, J = 8.9, 8.9 Hz), 6.83 (1H, dd, J = 8.7, 2.5 Hz), 6.80 
(1H, d, J = 2.3 Hz), 4.08 (2H, q, J = 7.2 Hz), 1.44 (3H, t, J = 7.2 Hz); 19F NMR (CDCl3): δ = 
-115.96 (s, 1F); 13C NMR (CDCl3): δ = 162.76 (d, J = 252 Hz), 162.06, 160.87, 155.26, 
139.88, 131.03 (d, J = 3.8 Hz), 130.17 (d, J = 8.1 Hz), 128.78, 123.56, 115.34 (d, J = 21.5 
Hz), 113.21, 113.04, 100.84, 64.18, 14.52; HRMS (ESI): m/z calcd for C17H13O3FNa 
[M+Na]+ 307.0741 Found 307.0741; IR (KBr): 1706, 1604, 1513, 1274, 1240, 1177, 822 cm
-1
 
 
3-(4-chlorophenyl)-7-ethoxy-2H-chromen-2-one (3n)  
 1H NMR (CDCl3): δ = 7.73 (1H, s), 7.62 (2H, d, J = 8.7 Hz), 7.40 
(1H, d, J = 8.7 Hz), 7.37 (2H, d, J = 8.4 Hz), 6.84 (1H, dd, J = 8.7, 2.3 Hz), 6.81 (1H, d, J = 
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2.3 Hz), 4.09 (2H, q, J = 7.2 Hz), 1.45 (3H, t, J = 7.1 Hz); 13C NMR (CDCl3): δ = 162.22, 
160.69, 155.37, 140.11, 134.37, 133.45, 129.66, 128.88, 128.59, 123.37, 113.31, 112.99, 
100.87, 64.22, 14.54; HRMS (ESI): m/z calcd for C17H13O3Na [M+Na]+ 323.0445 Found 
323.0438; IR (KBr): 1713, 1611, 1508, 1363, 1270, 818 cm
-1
 
 
3-(4-bromophenyl)-7-ethoxy-2H-chromen-2-one (3o)  
 1H NMR (CDCl3): δ = 7.73 (1H, s), 7.57-7.52 (4H,m), 7.40 (1H, 
d, J = 8.6 Hz), 6.84 (1H, dd, J = 8.6, 2.6 Hz), 6.81 (1H, d, J = 2.3 Hz), 4.06 (2H, q, J = 7.1, 
Hz), 1.45 (3H, t, J = 7.0 Hz); 13C NMR (CDCl3): δ = 162.25, 160.62, 155.39, 140.11, 133.93, 
131.55, 129.94, 128.90, 123.40, 122.60, 113.33, 113.00, 100.88, 64.23, 14.54; HRMS 
(ESI): m/z calcd for C17H13O3BrNa [M+Na]+ 366.9940 Found 366.9947; IR (KBr): 1711, 
1611, 1507, 1363, 1270, 1176, 817 cm
-1
 
 
7-ethoxy-3-(4-iodophenyl)-2H-chromen-2-one (3p)  
 1H NMR (CDCl3): δ = 7.73 (2H, d, J = 8.6 Hz), 7.72 (1H, s), 7.41 
(2H, d, J = 8.6 Hz), 7.39 (1H, d, J = 8.6 Hz), 6.83 (1H, dd, J = 8.6, 2.3 Hz), 6.80 (1H, d, J = 
2.3 Hz), 4.08 (2H, q, J = 7.1 Hz), 1.44 (3H, t, J = 7.0 Hz); 13C NMR (CDCl3): δ = 162.25, 
160.53, 155.38, 140.07, 137.50, 134.51, 130.08, 128.91, 123.44, 113.30, 112.98, 100.87, 
94.27, 64.22, 14.53; HRMS (ESI): m/z calcd for C17H13O3INa [M+Na]+ 414.9802 Found 
414.9809; IR (KBr): 1713, 1611, 1506, 1362, 1269, 1176, 816 cm
-1
 
 
ethyl 4-(7-ethoxy-2-oxo-2H-chromen-3-yl)benzoate (3q)  
 1H NMR (CDCl3): δ = 8.06 (2H, d, J = 8.9 Hz), 7.79 (1H, s), 
7.75 (2H, d, J = 8.7 Hz), 7.41 (1H, d, J = 8.9 Hz), 6.84 (1H, dd, J = 8.9, 2.5 Hz), 6.80 (1H, 
d, J = 2.5 Hz), 4.37 (2H, q, J = 7.3 Hz), 4.08 (2H, q, J = 7.2 Hz), 1.44 (3H, t, J = 7.2 Hz), 
1.38 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3): δ = 166.20, 162.42, 160.45, 155.51, 140.90, 
139.38, 130.09, 129.54, 129.07, 128.21, 123.40, 113.33, 112.90, 100.83, 64.22, 61.00, 
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14.50, 14.29; HRMS (ESI): m/z calcd for C20H18O5Na [M+Na]+ 361.1046 Found 
361.1057; IR (KBr): 1715, 1609, 1366, 1276, 1186, 1109, 783 cm
-1
 
 
7-ethoxy-3-(4-(trifluoromethyl)phenyl)-2H-chromen-2-one (3r)  
 1H NMR (CDCl3): δ = 7.79 (1H, s), 7.79 (2H, d, J = 8.2 Hz), 
7.66 (2H, d, J = 8.7 Hz), 7.43 (1H, d, J = 8.7 Hz), 6.86 (1H, dd, J = 8.7, 2.5 Hz), 6.82 (1H, 
d, J = 2.3 Hz), 4.09 (2H, q, J = 7.1 Hz), 1.45 (3H, t, J = 7.1 Hz); 19F NMR (CDCl3): δ = 
-65.51 (s, 3F); 13C NMR (CDCl3): δ = 162.55, 160.53, 155.59, 141.07, 138.58 (q, J = 1.3 
Hz), 130.25 (q, J = 33.2 Hz), 129.11, 128.69, 125.33 (q, J = 3.8 Hz), 124.04 (q, J = 276 Hz), 
123.11, 113.45, 112.85, 100.91, 64.29, 14.52; HRMS (ESI): m/z calcd for C18H13O3F3Na 
[M+Na]+ 367.0709 Found 357.0710; IR (KBr): 1713, 1612, 1331, 1274, 178, 1117, 1071, 849 
cm
-1
 
 
7-ethoxy-3-(4-nitrophenyl)-2H-chromen-2-one (3s)  
 1H NMR (CDCl3): δ = 8.26 (2H, d, J = 9.0 Hz), 7.88 (2H, d, J = 
8.7 Hz), 7.87 (1H,s), 7.46 (1H, d, J = 8.7 Hz), 6.88 (1H, dd, J = 8.7, 2.3 Hz), 6.83 (1H, d, J 
= 2.3 Hz), 4.11 (2H, q, J = 7.1 Hz) 1.46 (3H, t, J = 7.1 Hz); 13C NMR (CDCl3): δ = 162.98, 
160.19, 155.81, 147.41, 141.81, 141.52, 129.37, 129.14, 123.60, 122.08, 113.70, 112.67, 
100.92, 64.38, 14.52; HRMS (ESI): m/z calcd for C17H13O3INa [M+Na]+ 334.0686 Found 
334.0700; IR (KBr): 1712, 1610, 1524, 1347, 1275, 1224, 1037, 852 cm
-1
 
 
3-(2-bromophenyl)-7-ethoxy-2H-chromen-2-one (3t) 
 1H NMR (CDCl3): δ = 7.65 (1H, d, J = 7.8 Hz), 7.63 (1H, s), 
7.40-7.34 (3H, m), 7.25-7.21 (1H, m), 6.86-6.83 (2H, m), 4.10 (2H, q, J = 7.0 Hz), 1.45 (3H, 
t, J = 7.0 Hz); 13C NMR (CDCl3): δ = 162.33, 160.11, 155.80, 142.68, 136.07, 133.03, 
131.47, 129.91, 128.98, 127.40, 125.01, 123.81, 113.19, 112.45, 101.10, 64.22, 14.53; 
HRMS (ESI): m/z calcd for C17H13O3BrNa [M+Na]+ 366.9940 Found 366.9922; IR (KBr): 
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1734, 1615, 1356, 1274, 1180, 1125, 1036, 823 cm
-1
 
 
3-(3-bromophenyl)-7-ethoxy-2H-chromen-2-one (3u)  
 1H NMR (CDCl3): δ = 7.80 (1H, dd, J = 1.8, 1.8 Hz), 7.73 (1H, s), 
7.62 (1H, dd, J = 8.0, 0.9 Hz), 7.47 (1H, dt, J = 8.2, 0.9 Hz), 7.40 (1H, d, J = 8.9 Hz), 7.27 
(1H, t, J = 8.0 Hz), 6.84 (1H, dd, J = 8.7, 2.5 Hz), 6.80 (1H, d, J = 2.3 Hz), 4.08 (2H, q, J = 
7.2 Hz), 1.44 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3): δ = 162.35, 160.49, 155.44, 140.63, 
137.02, 131.31, 131.18, 129.85, 128.99, 127.05, 123.00, 122.40, 113.33, 112.88, 100.85, 
64.23, 14.52; HRMS (ESI): m/z calcd for C17H13O3BrNa [M+Na]+ 366.9940. Found 
366.9928; IR (KBr): 1714, 1605, 1276, 1177, 822, 787, 686 cm
-1
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Experimental section for section 3 
 
Contents 
1. General Method 
2. General Procedure for the Catalytic Dehydrogenation 
3. Mechanistic Studies 
4. Syntheses of Substrates 
5. Characterization of Target Compounds 
6. References 
 
1. General Method 
1H NMR spectra were recorded on JEOL ECX500 (500 MHz for 1H NMR and 125.65 
MHz for 13C NMR), and JEOL ECS400 (400 MHz for 1H NMR, 100 MHz for 13C NMR 
and 368 MHz for 19F NMR) spectrometer. For 1H NMR and 13C NMR, chemical shifts 
were reported in the scale relative to the solvent used as an internal reference. For 19F 
NMR, chemical shifts were reported relative to hexafluorobenzene (δ = 164.9 ppm) as 
an external reference. Electrospray ionization (ESI)-mass spectra were measured on a 
JEOL JMS-T100LC AccuTOF spectrometer for HRMS. Infrared (IR) spectra were 
recorded on a JASCO FT/IR 410 Fourier transform infrared spectrophotometer. Column 
chromatographies were performed with silica gel Merck 60 (230-400 mesh ASTM). GPC 
purification was conducted on a Japan Analytical Industry Co., Ltd. LC9210NEXT 
equipped with JAIGEL-1H and JAIGEL-2H, and CHCl3 was used as an eluent. All 
non-commercially available compounds were prepared and characterized as described 
in section 4 of this experimental section. Other reagents were purchased from Aldrich, 
Tokyo Chemical Industry Co., Ltd. (TCI), Kanto Chemical Co., Inc., and Wako Pure 
Chemical Industries, Ltd. and were used as received. Electrophilic boranes 1c,1 1d,2 1e, 
1f,3 1g, 1h4 or Lewis base 1j5 were prepared according to the literature procedure. 
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2. General Procedure for the Dehydrogenation of N-heterocycles 
 
2-Methyl-1,2,3,4-tetrahydroquinoline (2a) (36.1 μL, 0.25 mmol), 
tris(pentafluorophenyl)borane (1a) (6.4 mg, 0.0125 mmol) and p-xylene (0.5 mL) were 
added in a dry screw tube (diameter = 25 mm, height = 200 mm) under argon 
atmosphere.  The tube was capped and the reaction mixture was stirred for 22 hours at 
150 °C.  After cooling the reaction to room temperature, the mixture was passed 
through a short pad of alumina with degassed methanol under argon atmosphere and 
concentrated under reduced pressure. The crude mixture was subjected to column 
chromatography (EtOAc/n-hexane = 1/5), which afforded pure 3a (32.8 mg, 0.23 mmol) 
in 92% yield as colorless oil.  
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3. Mechanistic Studies 
a) Conditions for the 19F NMR investigations 
A solution of 2a (36.1 μL, 0.25 mmol) and tris(pentafluorophenyl)borane 1a (5.4 mg, 
0.011 mmol) in toluene-d8 (1.0 mL) was prepared in a flame-dried vial under inert 
atmosphere. The solution was transferred into a dry NMR tube, sealed, and subjected to 
19F NMR analysis. When the tube was warmed to 80 °C, resonances at 136 ppm, 161 
ppm, 166 ppm were observed. The relative integrals of those were approximately 2 (for 
136 ppm), 1 (for 160 ppm) and 2 (for 165 ppm).  
 
b) Conditions for the confirmation of H2 gas release by dual reactions 
  In one side of screwable two-chamber glass system (COware: 
http://www.sigmaaldrich.com/catalog/product/aldrich/744077?lang=ja&region=JP 
accessed on June 25th, 2016), tris(pentafluorophenyl)borane 1a (25.6 mg, 0.050 mmol) 
and 2-methyl-1,2,3,4-tetrahydroquinoline 2a (72.2 μL, 0.50 mmol) were dissolved in 
p-xylene (1.0 mL). In the other side of the apparatus, tris(triphenylphosphine)rhodium 
chloride (9.3 mg, 0.010 mmol) and cyclododecene 6 (191 μL, 1.0 mmol) were dissolved in 
benzene (1.0 mL). These two reactions share the same atmosphere so that only gaseous 
components can be transferred between sides. Then, the p-xylene solution side was 
heated to 120 °C while the benzene solution side was kept at room temperature. After 
48 hours, each reaction mixture was cooled to room temperature and passed through a 
short pad of alumina with CH2Cl2. The solvent was removed under reduced pressure, 
and each reaction mixture was subjected to 1H NMR analysis. According to the NMR 
spectra using 1,1,2,2-tetrachloroethane as an internal standard, yield of 
2-methylquinoline 3a was 78% and yield of cyclododecane 7 was 66%, respectively.   
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4. Syntheses and characterization of substrates 
a) Synthesis of 2c, 2g, 2i 
  These compounds were prepared as reported previously.6 
 
b) Synthesis of 2b, 2d, 2e 
  These compounds were prepared as reported previously.7 
 
c) Synthesis of 2f 
  2f was prepared as reported previously.8 
 
d) Synthesis of 2h 
6-methoxy-2-methyl-1,2,3,4-tetrahydroquinoline (2h) 
 
  The compound was synthesized with a similar procedure as a previous report.6 A 
suspension of 6-methoxy-2-methylquinoline (260 mg, 1.5 mmol), Hantzsch ester (912 
mg, 3.6 mmol) and diphenyl phosphate (3.8 mg, 0.015 mmol) in benzene (10 mL) was 
stirred at 60 °C for 22 hours. After cooled to room temperature, solvents were removed 
under reduced pressure. Purification by GPC afforded 2h (110.3 mg, 0.62 mmol) in 41% 
yield as colorless oil. 
 
6-methoxy-2-methyl-1,2,3,4-tetrahydroquinoline (2h) 
 NMR spectra of the obtained product were consistent with the 
reported one.9 
 
e) Synthesis of 2j 
6-chloro-2-methyl-1,2,3,4-tetrahydroquinoline (2j) 
 
  The compound was synthesized with a similar procedure as a previous report.6 A 
72 
 
suspension of 6-chloro-2-methylquinoline (178 mg, 1.0 mmol), Hantzsch ester (608 mg, 
2.4 mmol) and diphenyl phosphate (5.0 mg, 0.020 mmol) in benzene (6.7 mL) was stirred 
at 60 °C for 13 hours. After cooled to room temperature, solvents were removed under 
reduced pressure. Purification by column chromatography (EtOAc/n-hexane = 1/10) 
afforded 2j (150.6 mg, 0.83 mmol) in 83% yield as white solid. 
 
6-chloro-2-methyl-1,2,3,4-tetrahydroquinoline (2j) 
 NMR spectra of the obtained product were consistent with the 
reported one.9 
 
f) Synthesis of 2k 
6-bromo-2-methyl-1,2,3,4-tetrahydroquinoline (2k) 
 
  The compound was synthesized with a similar procedure as a previous report.6 A 
suspension of 6-bromo-2-methylquinoline (222 mg, 1.0 mmol), Hantzsch ester (608 mg, 
2.4 mmol) and diphenyl phosphate (5.0 mg, 0.020 mmol) in benzene (6.7 mL) was stirred 
at 60 °C for 13 hours. After cooled to room temperature, solvents were removed under 
reduced pressure. Purification by column chromatography (EtOAc/n-hexane = 1/10) 
afforded 2k (195.1 mg, 0.86 mmol) in 86% yield as white solid. 
 
6-bromo-2-methyl-1,2,3,4-tetrahydroquinoline (2k) 
 NMR spectra of the obtained product were consistent with the 
reported one.9 
 
g) Synthesis of 2l 
8-methyl-1,2,3,4-tetrahydroquinoline (2l) 
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  The compound was synthesized with a similar procedure as a previous report.6 A 
suspension of 8-methylquinoline (0.136 ml, 1.0 mmol), Hantzsch ester (608 mg, 2.4 
mmol) and diphenyl phosphate (2.5 mg, 0.010 mmol) in benzene (6.7 mL) was stirred at 
60 °C for 21 hours. After cooled to room temperature, solvents were removed under 
reduced pressure. Purification by column chromatography (EtOAc/n-hexane = 1/10) 
afforded 2l (131.4 mg, 0.89 mmol) in 89% yield as pale yellow oil. 
 
8-methyl-1,2,3,4-tetrahydroquinoline (2l) 
 NMR spectra of the obtained product were consistent with the reported 
one.10 
 
h) Synthesis of 2m 
1,2,3,4-tetrahydrobenzo[h]quinoline (2m) 
 
  The compound was synthesized with a similar procedure as a previous report.6 A 
suspension of benzo[h]quinoline (269 mg, 1.5 mmol), Hantzsch ester (912 mg, 3.6 mmol) 
and diphenyl phosphate (3.8 mg, 0.015 mmol) in benzene (10 mL) was stirred at 60 °C 
for 29 hours. After cooled to room temperature, solvents were removed under reduced 
pressure. Purification by column chromatography (EtOAc/n-hexane = 1/10) afforded 2m 
(210.7 mg, 1.15 mmol) in 77% yield as white solid. 
 
1,2,3,4-tetrahydrobenzo[h]quinoline (2m) 
 NMR spectra of the obtained product were consistent with the reported 
one.8 
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i) Synthesis of 2o 
cis-2,3-diphenyl-1,2,3,4-tetrahydroquinoxaline (2o) 
 
  To a stirred solution of 2,3-diphenylquinoxaline (424 mg, 1.5 mmol) in THF (5 mL), 
BH3•THF (1 M in THF; 6.0 mL: 6.0 mmol) was added. The mixture was heated to reflux 
and stirred for 19 hours. After cooled to room temperature, volatiles were removed 
under reduced pressure. The crude was suspended in 10% HCl aq. and stirred at 60 °C 
for 1 hour. Then, the mixture was basified with 10% NaOH aq. and extraction was 
performed three times with CH2Cl2. The combined organic layer was dried with MgSO4, 
filtered and concentrated under reduced pressure. Purification by column 
chromatography (EtOAc/n-hexane = 1/10) afforded 2o (357 mg, 1.25 mmol) in 83% yield 
as white solid. 
 
cis-2,3-diphenyl-1,2,3,4-tetrahydroquinoxaline (2o) 
 NMR spectra of the obtained product were consistent with the 
reported one.11 
 
j) Synthesis of 2r 
1-methylindoline (2r) 
 
  To a stirred suspension of indoline (562 μL, 5.0 mmol) and sodium hydride (60% in 
mineral oil; 300 mg, 7.5 mmol) in THF (10 mL), indomethane (467 μL, 7.5 mmol) was 
added dropwise. After 24 hours, water was added, and organic phase was extracted with 
CH2Cl2 three times. The combined organic layer was dried with MgSO4, filtered and 
concentrated under reduced pressure. Purification by column chromatography (Et3N/ 
CH2Cl2/n-hexane = 1/50/50) afforded 2r (167 mg, 1.26 mmol) in 25% yield as yellow oil. 
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1-methylindoline (2r) 
 NMR spectra of the obtained product were consistent with the reported 
one.12 
 
k) Synthesis of 2r 
3-methyl-1,5-diphenyl-4,5-dihydro-1H-pyrazole (2s)13 
 
  To a suspension of phenylhydrazine hydrochloride (795 mg, 5.5 mmol) and potassium 
acetate (491 mg, 5.0 mmol) in EtOH (25 mL), benzalacetone (746 mg, 5.0 mmol) was 
added. After 20 hours, water was added and the formed precipitate was filtered and 
washed with water. The crude product was purified by column chromatography 
(CH2Cl2/n-hexane = 2/3 to 1/1) to afford 2s (328 mg, 1.39 mmol) in 28% yield as orange 
solid.  
 
3-methyl-1,5-diphenyl-4,5-dihydro-1H-pyrazole (2s) 
 NMR spectra of the obtained product were consistent with the 
reported one.13 
 
l) Synthesis of 2t 
1,3,5-triphenyl-4,5-dihydro-1H-pyrazole (2t) 
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  To a solution of chalcone (1041 mg, 5.0 mmol) and phenylhydrazine hydrochloride 
(795 mg, 5.5 mmol) in EtOH (20 mL), 3 drops of concentrated H2SO4 was added. The 
mixture was stirred under reflux for 5 hours. Then, water was added, and precipitate 
was filtered and washed with water. The crude product was purified by column 
chromatography (EtOAc/n-hexane = 1/20) and 2t (1251 mg, 4.20 mmol) was obtained in 
84 % yield as white solid. 
 
1,3,5-triphenyl-4,5-dihydro-1H-pyrazole (2t) 
 NMR spectra of the obtained product were consistent with the 
reported one.14 
 
m) Synthesis of 2u, 2v 
  These compounds were prepared as reported previously.15 
 
n) Synthesis of 2w 
2-phenethyl-2,3-dihydrobenzo[d]thiazole (2w) 
 
  To a stirred solution of 2-aminobenzenethiol (1.07 mL, 10 mmol) in EtOH (40 mL), 
3-phenylpropanal (1.33 mL, 10 mmol) was added. After 16 hours, volatiles were 
removed under reduced pressure. Purification by column chromatography 
(EtOAc/n-hexane = 1/10) afforded 2w (1062 mg, 4.4 mmol) in 44% yield as white solid. 
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2-phenethyl-2,3-dihydrobenzo[d]thiazole (2w) 
1H NMR (CDCl3): δ = 7.34-7.31 (2H, m), 7.25-7.21 (3H, m), 7.10 
(1H, dd, J = 7.8, 1.2 Hz), 6.93 (1H, dt, J = 7.6, 1.5 Hz), 6.77 (1H, dt, J = 7.6, 1.2 Hz), 6.64 
(1H, dd, J = 8.1, 0.9 Hz), 5.25 (1H, t, J = 6.5 Hz), 4.02 (1H, s), 2.84-2.72 (2H, m), 2.19 (2H, 
dd, J = 14.3, 7.8 Hz); 13C NMR (CDCl3): δ = 146.37, 140.74, 128.45, 128.35, 127.24, 
126.06, 125.08, 121.90, 120.77, 110.85, 67.84, 40.09, 32.08; HRMS (ESI): m/z calcd for 
C15H15NSNa [M+Na]+ 264.0817 Found 264.0827; IR (KBr): 3352, 1577, 1473, 1404, 1275, 
1065, 786, 735, 717, 694 cm
-1
 
 
o) Synthesis of 2x 
2-(benzo[b]thiophen-2-yl)-1,2,3,4-tetrahydroquinoline (2x) 
 
A solution of benzo[b]thiophene (671 mg, 5.0 mmol) in Et2O (3.12 mL) was cooled to 
0 °C. Then, a solution of n-butyllithium (2.66 M in hexane: 1.88 mL, 5.0 mmol) was 
added dropwise. After warmed to room temperature, the solution was stirred for 1 hour. 
The solution of benzo[b]thiophen-2-yllithium was used for the next reaction. 
  N-(2,3-Dihydro-1H-inden-1-yl)-O-methylhydroxylamine was prepared according to 
the method reported by Miyata.7 To a stirred solution of 
N-(2,3-dihydro-1H-inden-1-yl)-O-methylhydroxylamine (106 mg, 0.65 mmol) in Et2O (20 
ml), the solution of benzo[b]thiophen-2-yllithium (1 M in Et2O/hexane: 1.95 mL, 1.95 
mmol) was added dropwise. After 25 minutes, water was added. Organic layer was 
separated, and water phase was extracted with CHCl3 three times. The combined 
organic layer was dried with MgSO4, filtered and concentrated under reduced pressure. 
Purification by column chromatography (CH2Cl2/n-hexane = 1/2) afforded 2x (136.1 mg, 
0.51 mmol) in 78% yield as white solid. 
 
2-(benzo[b]thiophen-2-yl)-1,2,3,4-tetrahydroquinoline (2x) 
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1H NMR (CDCl3): δ = 7.78 (1H, d, J = 8.1 Hz), 7.68 (1H, d, J = 7.7 
Hz), 7.32-7.28 (2H, m), 7.23 (1H, d, J = 12.9 Hz), 7.03-6.98 (2H, m), 6.68 (1H, t, J = 7.3 
Hz), 6.58 (1H, d, J = 8.0 Hz), 4.81 (1H, dd, J = 8.3, 3.2 Hz), 2.94-2.88 (1H, m), 2.81-2.75 
(1H, m), 2.28-2.24 (1H, m), 2.18-2.13 (1H, m); 13C NMR (CDCl3): δ = 149.60, 143.63, 
139.58, 139.14, 129.29, 126.96, 124.23, 123.97, 123.23, 122.44, 120.89, 120.08, 117.76, 
114.28, 52.33, 31.08, 25.69; HRMS (ESI): m/z calcd for C17H15NSNa [M+Na]+ 288.0817 
Found 288.0824; IR (KBr): 3349, 1584, 1480, 1309, 1254, 752 cm
-1 
 
p) Synthesis of S2a 
(2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanol (S2a) 
 
  To a stirred suspension of 2-methylquinoline-6-carboxylic acid (936 mg, 5.0 mmol) and 
WSCI•HCl (1150 mg, 6.0 mmol) in CH2Cl2 (20 mL), MeOH (2 mL) and pyridine (0.80 
mL, 10 mmol) were added successively. After 24 hours, the mixture was washed with 
water, dried with Na2SO4, filtered and concentrated under reduced pressure to afford 
S3b (707.7 mg, 3.52 mmol) in 70% yield as light brown solid. 
  S2b was synthesized with a similar procedure as a previous report.6 A suspension of 
S3b (338 mg, 1.68 mmol), Hantzsch ester (1021 mg, 4.03 mmol) and diphenyl phosphate 
(4.2 mg, 0.017 mmol) in benzene (11.2 mL) was stirred at 60 °C for 22 hours. After 
cooled to room temperature, solvents were removed under reduced pressure. 
Purification by column chromatography (acetone/n-hexane = 1/6) afforded S2b (287.9 
mg, 1.40 mmol) in 83% yield as white solid. 
To a stirred solution of S2b (103 mg, 0.50 mmol) in CH2Cl2 (1 mL) cooled at 0 °C, a 
solution of DIBAL (1 M in hexane, 1.5 mL, 1.5 mmol) was added dropwise. After 20 
minutes, EtOAc (5 mL) and saturated aqueous solution of Rochelle salt (10 mL) was 
added. After stirred for 1 hour at room temperature, the organic material was extracted 
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with EtOAc three times, dried with Na2SO4, filtered and concentrated under reduced 
pressure to afford S2a (83.5 mg, 0.47 mmol) in 94% yield as light pink solid. 
 
methyl 2-methylquinoline-6-carboxylate (S3b) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
 
methyl 2-methyl-1,2,3,4-tetrahydroquinoline-6-carboxylate (S2b) 
NMR spectra of the obtained product were consistent with the 
reported one.9 
 
 (2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanol (S2a) 
 1H NMR (CDCl3): δ = 6.95-6.93 (2H, m), 6.43 (1H, d, J = 8.1 Hz), 
4.47 (2H, s), 3.40-3.35 (1H, m), 2.84-2.78 (1H, m), 2.73-2.68 (1H, m), 1.94-1.89 (1H, m), 
1.59-1.52 (1H, m), 1.19 (3H, d, J = 6.3 Hz); 13C NMR (CDCl3): δ = 144.44, 129.36, 128.83, 
126.28, 121.07, 113.94, 65.45, 47.14, 29.96, 26.47, 22.47; HRMS (ESI): m/z calcd for 
C11H15NONa [M+Na]+ 200.1046 Found 200.1036; IR (KBr): 3278, 1613, 1507, 1343, 1306, 
1256, 1011, 825, 736 cm
-1
 
 
q) Synthesis of S2c 
2-(furan-2-yl)-1,2,3,4-tetrahydroquinoline (S2c) 
 
A solution of furan (600 μL, 8.3 mmol) in Et2O (3.12 mL) was cooled to 0 °C. Then, a 
solution of n-butyllithium (2.66 M in hexane: 2.26 mL, 6.0 mmol) was added dropwise. 
After warmed to room temperature, the solution was stirred for 1 hour. The suspension 
of furan-2-yllithium was used for the next reaction. 
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  N-(2,3-Dihydro-1H-inden-1-yl)-O-methylhydroxylamine was prepared according to 
the method reported by Miyata.7 To a stirred solution of 
N-(2,3-dihydro-1H-inden-1-yl)-O-methylhydroxylamine (245 mg, 1.5 mmol) in Et2O (30 
ml), the suspension of furan-2-yllithium (1 M in Et2O/hexane: 4.5 mL, 4.5 mmol) was 
added dropwise. After 30 minutes, water was added. Organic layer was separated, and 
water phase was extracted with CHCl3 three times. The combined organic layer was 
dried with Na2SO4, filtered and concentrated under reduced pressure. Purification by 
column chromatography (CH2Cl2/n-hexane = 1/2) afforded S2c (111.9 mg, 0.69 mmol) in 
46% yield as yellow oil. 
 
2-(furan-2-yl)-1,2,3,4-tetrahydroquinoline (S2c) 
 NMR spectra of the obtained product were consistent with the 
reported one.8 
 
s) Synthesis of S2e 
(2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanol (S2e) 
 
  The compound was synthesized with a similar procedure as a previous report.17 A 
mixture of 3-phenylpiperidine (479 μL, 3.0 mmol), CuI (38 mg, 0.2 mmol), PhI (224 μL, 
2.0 mmol), K3PO4 (849 mg, 4.0 mmol), ethylene glycol (223 μL, 4.0 mmol) and 
isopropanol (1.33 mL) was heated at 120 °C in a sealed tube under argon atmosphere. 
After cooled to room temperature, the mixture was dissolved in a mixture of water and 
CH2Cl2. After extraction with CH2Cl2 three times, the organic layer was dried with 
Na2SO4, filtered and concentrated under reduced pressure. Purification by column 
chromatography (CH2Cl2/n-hexane = 1/2) afforded S2e (195.8 mg, 0.82 mmol) in 27% 
yield as colorless oil. 
 
1,3-diphenylpiperidine (S2e) 
 1H NMR (CDCl3): δ = 7.39-7.35 (2H, m), 7.33-7.26 (5H, m), 7.00 (2H, dd, J = 
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7.8, 0.9 Hz), 6.89-6.85 (1H, m), 3.82-3.78 (2H, m), 3.00-2.94 (1H, m), 2.84-2.78 (2H, m), 
2.09-2.06 (1H, m), 1.93-1.83 (2H, m), 1.73-1.64 (1H, m); 13C NMR (CDCl3): δ = 151.52, 
144.26, 129.06, 128.46, 127.22, 126.50, 119.27, 116.48, 57.01, 50.08, 42.50, 31.50, 25.39. 
HRMS (ESI): m/z calcd for C17H20N [M+H]+ 238.1590 Found 238.1583; IR (KBr): 2929, 
1599, 1495, 1384, 1239, 1119, 1032, 754, 698 cm
-1
 
 
r) Synthesis of S2f 
  This compound was prepared as reported previously.17 
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5. Characterization of Target Compounds 
2-methylquinoline (3a) 
 NMR spectra of the obtained product were consistent with the reported 
one.18 
 
2-butylquinoline (3b) 
 NMR spectra of the obtained product were consistent with the 
reported one.18 
 
2-phenylquinoline (3c) 
 NMR spectra of the obtained product were consistent with the 
reported one.8 
 
2-(p-tolyl)quinoline (3d) 
 NMR spectra of the obtained product were consistent with the 
reported one.19 
 
2-(4-chlorophenyl)quinoline (3e) 
 NMR spectra of the obtained product were consistent with the 
reported one.19 
 
2-(4-(methylthio)phenyl)quinoline (3f) 
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 NMR spectra of the obtained product were consistent with the 
reported one.8 
 
2,6-dimethylquinoline (3g) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
 
6-methoxy-2-methylquinoline (3h) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
 
6-fluoro-2-methylquinoline (3i) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
 
6-chloro-2-methylquinoline (3j) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
 
6-bromo-2-methylquinoline (3k) 
 NMR spectra of the obtained product were consistent with the 
reported one.16 
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8-methylquinoline (3l) 
 NMR spectra of the obtained product were consistent with the reported 
one.8 
 
benzo[h]quinoline (3m) 
 NMR spectra of the obtained product were consistent with the reported 
one.8 
 
2,3-dimethylquinoxaline (3n) 
 NMR spectra of the obtained product were consistent with the reported 
one.11 
 
2,3-dimethylquinoxaline (3o) 
 NMR spectra of the obtained product were consistent with the 
reported one.20 
 
1H-indole (3p) 
 NMR spectra of the obtained product were consistent with the reported one.21 
 
2-methyl-1H-indole (3q) 
 NMR spectra of the obtained product were consistent with the reported 
one.22 
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1-methyl-1H-indole (3r) 
 NMR spectra of the obtained product were consistent with the reported 
one.22 
 
3-methyl-1,5-diphenyl-1H-pyrazole (3s) 
 NMR spectra of the obtained product were consistent with the 
reported one.23 
 
1,3,5-triphenyl-1H-pyrazole (3t) 
 NMR spectra of the obtained product were consistent with the 
reported one.24 
 
2-phenylbenzo[d]thiazole (3u) 
 NMR spectra of the obtained product were consistent with the 
reported one.25 
 
2-(naphthalene-1-yl)benzo[d]thiazole (3v) 
 NMR spectra of the obtained product were consistent with the 
reported one.26 
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2-phenethylbenzo[d]thiazole (3w) 
 NMR spectra of the obtained product were consistent with the 
reported one.27 
 
2-(benzo[b]thiophen-2-yl)quinoline (3x) 
 NMR spectra of the obtained product were consistent with the 
reported one.28 
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